Company Page
Most Recent Insiders Activity
| Transaction Date | Company Name | Insider Name (Title) | Activity | Stock | Acquired or Disposed | Shares | Price range | Amount |
|---|---|---|---|---|---|---|---|---|
| 2024-11-18 | IRONWOOD PHARMACEUTICALS INC | Davis Andrew
(SVP, Chief Business Officer) |
S | Class A Common Stock | D | 5360 | $4.08 - $4.08 | $21,868 |
| 2024-11-18 | IRONWOOD PHARMACEUTICALS INC | Emany Sravan Kumar
(SVP, COO and CFO) |
S | Class A Common Stock | D | 11001 | $4.08 - $4.08 | $44,884 |
| 2024-09-16 | IRONWOOD PHARMACEUTICALS INC | Sarissa Capital M...
(AtLeastTenPercentOwner) |
A | Class A Common Stock | A | 3282 | $0.00 - $0.00 | $0 |
| 2024-08-12 | IRONWOOD PHARMACEUTICALS INC | Silver Ronald
(Principal Accounting Officer) |
S | Class A Common Stock | D | 3107 | $4.27 - $4.27 | $13,266 |
| 2024-06-06 | IRONWOOD PHARMACEUTICALS INC | Moukheibir Catherine
(Director) |
S | Class A Common Stock | D | 80000 | $6.36 - $6.61 | $517,693 |
Activity types
| A | Grant, award or other acquisition |
| C | Conversion of Derivative or Security |
| D | Disposition to the issuer of issuer equity securities |
| E | Expiration of short derivative position |
| F | Payment of exercise price or tax liability |
| G | Bona fide Gift |
| H | Expiration (or cancellation) of long derivative position with value received |
| I | Discretionary Transaction |
| J | Other acquisition or disposition |
| K | Transaction in equity swap or instrument with similar characteristics |
| L | Small Acquisition |
| M | Exercise or conversion of derivative security |
| O | Exercise of out-of-the-money derivative security |
| P | Open Market Purchase |
| S | Open Market Sale |
| U | Disposition pursuant to a tender of shares in a change of control transaction |
| V | Transaction Voluntarily Reported |
| X | Exercise of in-the-money or at-the-money derivative security |
| Z | Deposit into or withdrawal from voting trust |